Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

“Money has returned to the market”: Envigo mulls biopharma role in preclinical recovery

29-Sep-2015 - Demand for biopharmaceutical testing is in part responsible for higher capacity utilisation but, despite encouraging signs, it is too early to say if preclinical pricing will improve accordingly says Envigo.

Drug delivery tech contractor 3M teams with MedImmune on cancer drug development

28-Sep-2015 - Contractor 3M Drug delivery has licensed a molecule with potential as a cancer treatment to MedImmune.

Venn offers $7.2m for Kinesis to boost toxicology testing offering

22-Sep-2015 - Venn Life Sciences has bid €6.5m ($7.2m) for preclinical CRO Kinesis Pharma BV in a move prompted by increased Big Pharma focus of efficient early phase drug discovery.

Covance mulls sacking 130 UK staff at ex Sanofi site; Opens 2nd cGMP pharmacy in US

22-Sep-2015 - Covance has warned 130 UK employees they could lose their jobs next month when a 5-year contract with Sanofi comes to an end.

Labcorp: Covance not adding capacity despite preclinical recovery

18-Sep-2015 - Covance will not add more capacity in the near future despite increased demand and improving preclinical sector pricing, Labcorp’s management says.

News in brief

Selvita opens two US offices and sets up Selvita Inc

18-Sep-2015 - Polish preclinical services company Selvita has opened offices in Boston and San Francisco in the US citing proximity to customers as the driver.

Evotec ups 2015 forecast for second time in two months citing Big Pharma deals

16-Sep-2015 - Evotec AG has raised its revenue expectations twice in as many months, predicting that contracts with Big Pharma customers will drive growth.

Pfizer calls on Evotec for tissue fibrosis drug discovery

10-Sep-2015 - Evotec has added Pfizer to its roster of Big Pharma partners through a drug discovery agreement focused on tissue fibrosis.

Agilent adding metabolism analysis tech in $235m Seahorse acquisition

10-Sep-2015 - Agilent Technologies has inked a deal to acquire Seahorse Bioscience, adding a cell metabolism analysis platform to its lead development and preclinical offerings.

Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation

02-Sep-2015 - Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.

WuXi enters strategic lab testing partnership with HK-based firm

28-Aug-2015 - WuXi PharmaTech has signed a strategic partnership deal to provide exclusive laboratory testing services to Hong Kong-headquartered Lee’s Pharmaceutical.

Anti-Nazi laws and a lack of alternatives: Factors slowing adoption of non-animal models

24-Aug-2015 - Laws prompted by Nazi atrocities combined with efficacy concerns about the few available alternatives mean the drug industry still favours animal models for preclinical research according to experts.

Preclinical firms donate mouse models for rare disease study

24-Aug-2015 - Animal model maker Taconic Biosciences has announced it will use CRISPR-Cas9 technology to breed custom mice to study Vici Syndrome.

$47m innovation facility built in Nottingham, UK

21-Aug-2015 - The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture...

Takeda invests in microdose tech collaborator Presage Biosciences

20-Aug-2015 - Takeda has invested in Presage Biosciences whose tech platform is designed to let pharmas test multiple cancer drug combinations in a single trial.

Concept Life Sciences buys UK toxicology biz

18-Aug-2015 - British CRO Concept Life Sciences has bought toxicology business CXR Biosciences, its fourth acquisition since it formed in July 2014.

News in brief

BASi sees Q3 profit rise due to early preclinical project terminations

17-Aug-2015 - One of the smaller contract research providers -- Bioanalytical Systems (BASi) – has reported modest revenue and profit gains for Q3. 

Charles River plans cautious approach to re-opening of Shrewsbury preclinical site

14-Aug-2015 - After months of speculation , Charles River Laboratories has decided to move forward with the re-opening of its early-stage research site in Shrewsbury, Massachusetts sometime in the first quarter of 2016.

Probe opprobrium: Scientists hope reagent database will improve drug research

22-Jul-2015 - Poor biochemical probes mean some drug discovery research is wasted according to academics behind a website intended to help biopharmaceutical developers choose the best reagents.

Independent lab network enters CRO market with acquisition of ABC Laboratories

22-Jul-2015 - EAG (Evans Analytical Group), an independent laboratory network, has acquired Missouri-based Analytical Bio-Chemistry Laboratories (ABC Labs). Financial terms of the transaction were not disclosed. 

Stem Cell Theranostics secures "freedom to operate" in IP deal with GE Healthcare

21-Jul-2015 - Stem Cell Theranostics has secured rights to the technology it uses to make cellular heart disease models for drug development through a deal with GE Healthcare.

Aptuit expands to bring on later-stage capabilities following client demand

14-Jul-2015 - CDMO (contract development and manufacturing organization) Aptuit is investing in additional scale and capabilities at its Italian site to augment its 1600L scale API capability and to add a commercial...

Heating issues caused death of 39 Guinea pigs at JHP Pharma facility

10-Jul-2015 - Par Pharmaceuticals says it has addressed its temperature-control system at a Michigan facility after overheating caused the death of 39 guinea pigs.

News in brief

Parexel expands model-based drug development services

10-Jul-2015 - Massachusetts-based CRO Parexel has expanded its services and capabilities in model-based drug development (MBDD) via its Quantitative Clinical Development (QCD) unit.  

News in brief

SCRS makes Covance its fifth CRO partner

26-Jun-2015 - The Society for Clinical Research Sites (SCRS), a trade organization representing the interests of clinical research sites, has announced a two-year partnership with LabCorp’s Covance. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...